Willing oneself better on placebo - Effective in its own right

Lancet

Volumn 364, Issue 9430, 2004, Pages 227-228

  Stoessl, A Jon ^a   De La Fuente Fernández, Raúl ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Universidad de La Coruña   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

BRAIN DEPTH STIMULATION; BRAIN REGION; CLINICAL TRIAL; CORRELATION ANALYSIS; DEPRESSION; DOPAMINE RELEASE; FITNESS; HUMAN; NOTE; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 3242675231     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16689-0     Document Type: Note

References (18)

1. McRae C, Cherin E, Yamazaki TG, et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry. 61:2004;412-420
2. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 344:2001;710-719
3. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 54:2003;403-414
4. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 23:2003;4315-4323
5. Kirsch I. Conditioning, expectancy, and the placebo effect: comment on Stewart-Williams and Podd (2004). Psychol Bull. 130:2004;341-343
6. de la Fuente-Fernandez R. Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease. Parkinsonism Relat Disord. 10:2004;125-127
7. Goetz CG, Leurgans S, Raman R. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord. 17:2002;283-288
8. Watts RL, Freeman T B, Hauser RA, et al. A double-blind, randomized, controlled, multicenter clinical trial of the safety and efficacy of sterotaxic intrastriatal implantation of fetal procine ventral mesencephalic tissue (Neurocell™-PD) vs. imitation surgery in patients with Parkinson's disease (PD). Parkinsonism Relat Disord 2001; 7: S87 (abstr).
9. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 2:1978;654-657
10. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia - imaging a shared neuronal network. Science. 295:2002;1737-1740
11. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am.J Psychiatry. 159:2002;728-737
12. de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science. 293:2001;1164-1166
13. Benedetti F, Colloca L, Torre E, et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci. 7:2004;587-588
14. de la Fuente-Fernandez R, Phillips AG, et al. Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res. 136:2002;359-363
15. Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 303:2004;1162-1167
16. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 344:2001;1594-1602
17. Clark PA. Placebo surgery for Parkinson's disease: do the benefits outweigh the risks? J Law Med Ethics. 30:2002;58-68
18. Weijer C. I need a placebo like I need a hole in the head. J Law Med Ethics. 30:2002;69-72